Medtronic, Inc. To Form Panel After Blood Pressure Device Fails Key Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medtronic Inc on Monday said it will convene an independent panel of experts to make recommendations on the future of its experimental treatment for high blood pressure after the device failed to meet the key goal of a clinical study.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC